Immunity, Inflammation and Disease · Published 2026-05-01 · DOI 10.1002/iid3.70445
ABSTRACT Background The Epstein‐Barr virus (EBV) and human herpesvirus 6 (HHV‐6) are frequently linked to neuropsychiatric illnesses such as multiple sclerosis, depression, and chronic fatigue syndrome/myalgic encephalomyelitis. These viruses may induce autoimmune reactions by molecular mimicry, leading to damage to self‐epitopes in the central nervous system (CNS). Objective This study seeks to explore the common pentapeptides present in EBV and HHV‐6 viral antigens alongside various CNS‐related proteins via molecular mimicry. Additionally, it will assess the immunogenicity of these shared pentapeptides in T and B cells. Method Sequence alignment was conducted to assess molecular mimicry between 32 EBV and HHV‐6 antigens and 10 CNS autoantigens. Protein sequences were obtained from UniProt, structural homology was analyzed using AlphaFold and PyMol, and shared pentapeptides were identified with Alignmentaj. Immunogenicity was assessed via the Immune Epitope Database (IEDB) for potential T‐ and B‐cell activation. Results A total of 91 mimicry pentapeptides were identified between viral antigens (42 EBV and 49 human HHV‐6), and 10 CNS proteins. Notably, synapsin (SYN)1 exhibited the highest mimicry, sharing 13 pentapeptides with (7 with EBV and 6 with HHV‐6) viral antigens such as EBV nuclear antigen (EBNA)1, EBNA6, latent membrane protein (LMP)1, and early antigen diffused (EA‐D). Myelin proteins, including myelin‐associated glycoprotein with 12 shared pentapeptides, myelin basic protein with 9, and myelin‐oligodendrocyte glycoprotein with 5, displayed immune cross‐reactivity with EBV/HHV‐6 antigens. EBNA1, EBNA2, EBNA6, LMP1, LMP2, EA‐D, and BLLF1 structurally resemble CNS autoantigens and act as immunoreactive epitopes for human T and B cells. Except for EBNA2 and protein U94, all share immunogenic pentapeptide sequences with SYN1. Conclusion Shared pentapeptides suggest a link between viral infections and CNS autoimmunity. Further research is needed to clarify molecular mechanisms and explore targeted therapies to mitigate virus‐induced neuroinflammation.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →